Výsledky vyhľadávania - "Cost-Benefit Analysis/methods"
-
1
Autori: Gandjour, Afschin
Zdroj: BMC Health Serv Res
BMC Health Services Research, Vol 24, Iss 1, Pp 1-7 (2024)Predmety: Health-economic evaluations, Models, Economic, Clinical Trials, Phase III as Topic, Modeling, Phase III clinical trial, Research, Cost-effectiveness, Humans [MeSH], Cost-Benefit Analysis/methods [MeSH], Models, Economic [MeSH], Clinical Trials, Phase III as Topic [MeSH], Study protocol, Cost-Benefit Analysis, Humans, Public aspects of medicine, RA1-1270
-
2
Autori:
Predmety: adaptive governance, Regulatory Capture, Agricultural policy, Common agricultural policy, Multi-Criteria Decision-Making, MCDM, Independent Regulatory Authority, Cost-Benefit Analysis, Cost-Benefit Analysis/methods, Cost-Benefit Analysis/standards, Cost-Benefit Analysis/economics, Cost-Benefit Analysis/organization & administration, Cost-Benefit Analysis/legislation & jurisprudence, Cost-Benefit Analysis/statistics & numerical data, CBA, Iran, Governance, Agricultural product, Agricultural planning, Policy, Policy Making, Budget policy, Government policy, Policy guideline, Policy planning
Relation: https://zenodo.org/communities/civi-veterinary-iran/; https://zenodo.org/records/17238526; oai:zenodo.org:17238526; https://doi.org/10.22541/au.175925382.27356640/v1
-
3
Autori: a ďalší
Zdroj: BMC Geriatr
BMC Geriatrics, Vol 24, Iss 1, Pp 1-12 (2024)Predmety: Female [MeSH], Health-economic evaluation, Aged, 80 and over [MeSH], Vertebral fractures, Osteoporotic Fractures/therapy [MeSH], Humans [MeSH], Cost-Benefit Analysis/methods [MeSH], Orthogeriatric co-management, Spinal Fractures/therapy [MeSH], Pelvic fractures, Retrospective Studies [MeSH], Spinal Fractures/economics [MeSH], Germany/epidemiology [MeSH], Osteoporotic Fractures/economics [MeSH], Male [MeSH], Research, Osteoporotic Fractures/epidemiology [MeSH], Pelvic Bones/injuries [MeSH], Insurance claims data, Health Care Costs [MeSH], Aged, 80 and over, Male, Cost-Benefit Analysis, RC952-954.6, Health Care Costs, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Geriatrics, Germany, Humans, Spinal Fractures, Female, Pelvic Bones, Osteoporotic Fractures, Retrospective Studies
-
4
Autori: a ďalší
Zdroj: BMC Psychiatry
BMC Psychiatry, Vol 24, Iss 1, Pp 1-11 (2024)Predmety: Mental Health Services, Slovakia, Cost-Benefit Analysis, Ecological Momentary Assessment, RC435-571, 4202 Epidemiology, Europe [MeSH], Study Protocol, Ecological Momentary Assessment [MeSH], Humans [MeSH], Cost-Benefit Analysis/methods [MeSH], mHealth, Multicenter Studies as Topic [MeSH], Slovakia [MeSH], Randomized Controlled Trials as Topic [MeSH], Mental Disorders/economics [MeSH], Germany [MeSH], Mental Health Services/economics [MeSH], Mental Disorders/therapy [MeSH], Experience Sampling Method, Belgium [MeSH], 1117 Public Health and Health Services, 03 medical and health sciences, 0302 clinical medicine, name=Psychiatry and Mental health, Belgium, Germany, Humans, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Psychiatry, Science & Technology, Mental Disorders, 3202 Clinical sciences, 1103 Clinical Sciences, DEPRESSION, 5203 Clinical and health psychology, 3. Good health, Europe, 1701 Psychology, Life Sciences & Biomedicine
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38915006
https://doaj.org/article/39056dc0984d48ab8770143c3eff917b
https://research.tilburguniversity.edu/en/publications/e2ff8071-f477-4f34-83c1-986c4de597a8
https://doi.org/10.1186/s12888-024-05839-4
https://lirias.kuleuven.be/handle/20.500.12942/745680
https://doi.org/10.1186/s12888-024-05839-4
https://repository.publisso.de/resource/frl:6506222 -
5
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Value in Health. 25:390-399
Predmety: Technology Assessment, Biomedical, Technology Assessment, Biomedical/methods, Cost-Benefit Analysis, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Cost-Benefit Analysis/methods, Journal Article, SDG 13 - Climate Action, Humans, health technology assessment, Therapies, Investigational/economics, Retrospective Studies, advanced therapies, Health Policy, Therapies, Investigational, Public Health, Environmental and Occupational Health, Uncertainty, advanced therapy medicinal products, Insurance, Health, Reimbursement/economics, gene therapy, 3. Good health, Europe, Insurance, Health, Reimbursement, cell therapy, 0305 other medical science, Ethical Analysis
Popis súboru: application/pdf
Prístupová URL adresa: http://www.valueinhealthjournal.com/article/S1098301521017538/pdf
https://pubmed.ncbi.nlm.nih.gov/35227451
https://eprints.gla.ac.uk/260366/1/260366.pdf
https://dspace.library.uu.nl/handle/1874/446974
https://dspace.library.uu.nl/handle/1874/417731
https://dspace.library.uu.nl/handle/1874/419056 -
6
Autori: a ďalší
Zdroj: Journal of medical Internet research, vol. 26, pp. e52077
Predmety: Humans, Mobile Applications/economics, Cost-Benefit Analysis/methods, Medication Errors/prevention & control, Medication Errors/economics, Child, Epinephrine/economics, Epinephrine/administration & dosage, Epinephrine/therapeutic use, Emergency Medical Services/economics, Norepinephrine/economics, Norepinephrine/therapeutic use, Norepinephrine/administration & dosage, Midazolam/therapeutic use, Midazolam/economics, Midazolam/administration & dosage, Dopamine/economics, Dopamine/therapeutic use, Pediatrics/economics, Pediatrics/methods, Cost-Effectiveness Analysis, PedAMINES, Pediatric Accurate Medication in Emergency Situations, Switzerland, adverse drug event, ambulance care, child care, cost-effectiveness, dopamine, economic evaluation
Popis súboru: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/39454199; info:eu-repo/semantics/altIdentifier/eissn/1438-8871; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_502F8D2ECD2F8; https://serval.unil.ch/notice/serval:BIB_502F8D2ECD2F; https://serval.unil.ch/resource/serval:BIB_502F8D2ECD2F.P001/REF.pdf
-
7
Autori: a ďalší
Zdroj: Value Health
Keetharuth, A D, Rowen, D, Bjorner, J B & Brazier, J 2021, ' Estimating a Preference-Based Index for Mental Health From the Recovering Quality of Life Measure : Valuation of Recovering Quality of Life Utility Index ', Value in Health, vol. 24, no. 2, pp. 281-290 . https://doi.org/10.1016/j.jval.2020.10.012Predmety: Adult, Male, Quality of Life/psychology, Adolescent, Psychometrics, Cost-Benefit Analysis, Health Status, Hope, Young Adult, 03 medical and health sciences, Leisure Activities, 0302 clinical medicine, Preference-Based Assessment, Surveys and Questionnaires, Cost-Benefit Analysis/methods, 80 and over, Mental Health/economics, Humans, Interpersonal Relations, Aged, Aged, 80 and over, Surveys and Questionnaires/standards, Middle Aged, 3. Good health, Mental Health, Socioeconomic Factors, Personal Autonomy, Quality of Life, Female
Popis súboru: application/pdf
Prístupová URL adresa: http://www.valueinhealthjournal.com/article/S1098301520344600/pdf
https://pubmed.ncbi.nlm.nih.gov/33518035
https://eprints.whiterose.ac.uk/166910/12/1-s2.0-S1098301520344600-main.pdf
https://eprints.whiterose.ac.uk/166910/
https://www.sciencedirect.com/science/article/pii/S1098301520344600
https://pubmed.ncbi.nlm.nih.gov/33518035/
https://europepmc.org/article/PMC/PMC7871010
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871010
https://www.ncbi.nlm.nih.gov/pubmed/33518035
https://curis.ku.dk/ws/files/286929445/Estimating_a_Preference_Based_Index_for_Mental_Health_From_the_Recovering_Quality_of_Life_Measure.pdf -
8
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Ombelet, W, van Eekelen, R, McNally, A, Ledger, W, Doody, K & Farquhar, C 2020, 'Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment?', Fertility and Sterility, vol. 114, no. 6, pp. 1141-1148. https://doi.org/10.1016/j.fertnstert.2020.10.029
Predmety: Ovulation Induction/economics, Family Characteristics, Infertility/economics, Cost-Benefit Analysis, Fertilization in Vitro, Insemination, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Ovulation Induction, Infertility, Cost-Benefit Analysis/methods, Fertilization in Vitro/economics, Humans, Artificial/economics, Insemination, Artificial
Popis súboru: application/pdf
Prístupová URL adresa: http://www.fertstert.org/article/S0015028220325437/pdf
https://pubmed.ncbi.nlm.nih.gov/33280720
https://pubmed.ncbi.nlm.nih.gov/33280720/
https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fc6640ebc-405f-4203-b6d4-7a691f6acf9e
https://www.ncbi.nlm.nih.gov/pubmed/33280720
https://www.fertstert.org/article/S0015-0282(20)32543-7/fulltext
https://europepmc.org/article/MED/33280720
https://researchinformation.amsterdamumc.org/en/publications/should-couples-with-unexplained-infertility-have-three-to-six-cyc
https://research.vumc.nl/en/publications/87100ce0-8dbc-4fa6-afa4-2c9d72b5b0ce
http://hdl.handle.net/1942/33458 -
9
Autori: a ďalší
Zdroj: Evaluation of Novel Approaches to Software Engineering Communications in Computer and Information Science. :373-403
Predmety: Adaptation space, CBAM, Cost-Benefit Analysis Method, Internet-of-Things, IoT, Machine learning, MAPE, Models at runtime, Self-adaptation, Statistical model checking, Adaptive systems, Decision making, E-learning, Feedback, Internet of things, Learning systems, Model checking, Online systems, Cost benefit analysis methods, Models at run time, Self adaptation, Cost benefit analysis, Software Technology, Programvaruteknik
Popis súboru: print
Prístupová URL adresa: https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-94592
-
10
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: LIR!C study group 2020, 'Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907. https://doi.org/10.1016/S2468-1253(20)30117-5
Predmety: Adult, Male, Cost-Benefit Analysis, Adrenal Cortex Hormones/therapeutic use, Crohn Disease/etiology, Laparoscopy/methods, Cecum/pathology, 03 medical and health sciences, 0302 clinical medicine, Crohn Disease, Gastrointestinal Agents, Adrenal Cortex Hormones, Ileum, Cost-Benefit Analysis/methods, Journal Article, Humans, Immunologic Factors, Comparative Study, Cecum, Retrospective Studies, Hepatology, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Tumor Necrosis Factor-alpha, Gastroenterology, Middle Aged, Ileum/pathology, Immunologic Factors/therapeutic use, Infliximab, 3. Good health, Multicenter Study, Infliximab/therapeutic use, Treatment Outcome, Randomized Controlled Trial, Gastrointestinal Agents/therapeutic use, Quality of Life, Female, Laparoscopy, Follow-Up Studies
Popis súboru: application/pdf
Prístupová URL adresa: https://pure.rug.nl/ws/files/135981534/1_s2.0_S2468125320301175_main.pdf
https://pubmed.ncbi.nlm.nih.gov/32619413
https://hdl.handle.net/11370/517b7d28-a074-49ef-8858-0d86d0dcfb93
https://research.rug.nl/en/publications/517b7d28-a074-49ef-8858-0d86d0dcfb93
https://doi.org/10.1016/S2468-1253(20)30117-5
https://research.rug.nl/en/publications/laparoscopic-ileocaecal-resection-versus-infliximab-for-terminal-
https://www.thelancet.com/pdfs/journals/langas/PIIS2468-1253(20)30117-5.pdf
https://www.sciencedirect.com/science/article/abs/pii/S2468125320301175
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30117-5/fulltext
https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F6b161d20-dcfe-48e3-8424-87707c5abd35
https://www.ncbi.nlm.nih.gov/pubmed/32619413
https://research.vumc.nl/en/publications/441f4100-0bbf-4673-b366-0ff13f60e9de
https://dspace.library.uu.nl/handle/1874/440552 -
11
Autori: a ďalší
Zdroj: Value in Health. 20(1)
Predmety: Generic health relevance, Good Health and Well Being, Biomarkers, Cost-Benefit Analysis, Evidence-Based Practice, Humans, Information Systems, Precision Medicine, Remote Sensing Technology, Technology Assessment, Biomedical, Telemedicine, cost-benefit analysis methods, digital medicine, individualized medicine, personalized medicine, Public Health and Health Services, Applied Economics, Health Policy & Services
Popis súboru: application/pdf
-
12
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Lancet HIV
Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa 2018, 'Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa : a modelling study', The Lancet HIV, vol. 5, no. 3, pp. e146-e154. https://doi.org/10.1016/S2352-3018(17)30190-X
E154
E146
Phillips, A N, Cambiano, V, Nakagawa, F, Revill, P, Jordan, M R, Hallett, T B, Doherty, M, De Luca, A, Lundgren, J D, Mhangara, M, Apollo, T, Mellors, J, Nichols, B, Parikh, U, Pillay, D, Rinke de Wit, T, Sigaloff, K, Havlir, D, Kuritzkes, D R, Pozniak, A, van de Vijver, D, Vitoria, M, Wainberg, M A, Raizes, E, Bertagnolio, S & Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa 2018, ' Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa : a modelling study ', The Lancet HIV, vol. 5, no. 3, pp. e146-e154 . https://doi.org/10.1016/S2352-3018(17)30190-XPredmety: DOLUTEGRAVIR, 3-Ring/economics, Cost-Benefit Analysis, HIV Infections, Medical and Health Sciences, Piperazines, 0302 clinical medicine, ANTIRETROVIRAL THERAPY, Heterocyclic Compounds, Models, Cost-Benefit Analysis/methods, INFECTION, Health Policy, 1. No poverty, Middle Aged, Heterocyclic Compounds, 3-Ring/economics, 3. Good health, Infectious Diseases, Models, Economic, Treatment Outcome, Medical Microbiology, 6.1 Pharmaceuticals, HIV/AIDS, Public Health, Infection, Life Sciences & Biomedicine, Heterocyclic Compounds, 3-Ring, Adult, Adolescent, Pyridones, Immunology, EMC OR-01, HIV Infections/drug therapy, Economic, 3-Ring, DIAGNOSIS, Article, Young Adult, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Health Sciences, Oxazines, Humans, HIV Integrase Inhibitors, Africa South of the Sahara, Science & Technology, Biomedical and Clinical Sciences, HIV Integrase Inhibitors/economics, Evaluation of treatments and therapeutic interventions, CARE, Good Health and Well Being, Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa, Antimicrobial Resistance
Popis súboru: application/pdf
Prístupová URL adresa: http://www.thelancet.com/article/S235230181730190X/pdf
https://pubmed.ncbi.nlm.nih.gov/29174084
https://eprints.whiterose.ac.uk/124851/1/1_s2.0_S235230181730190X_main.pdf
https://pubmed.ncbi.nlm.nih.gov/29174084/
http://europepmc.org/articles/PMC5843989
https://eprints.whiterose.ac.uk/124851/
https://discovery.ucl.ac.uk/10039893/
http://www.ncbi.nlm.nih.gov/pubmed/29174084
https://stacks.cdc.gov/view/cdc/52439
https://research.vumc.nl/en/publications/7a687b61-5eef-49f8-a1e9-d59a3efc5a72
http://hdl.handle.net/10044/1/60391
https://curis.ku.dk/ws/files/211820407/1_s2.0_S235230181730190X.pdf
https://discovery-pp.ucl.ac.uk/id/eprint/10039893/ -
13
Autori: a ďalší
Zdroj: The Lancet, Vol. 391, No 10137 (2018) pp. 2356-2367
Lancet Low Back Pain Series Working Group 2018, ' What low back pain is and why we need to pay attention ', Lancet Oncology, vol. 391, no. 10137, pp. 2356-2367 . https://doi.org/10.1016/S0140-6736(18)30480-XPredmety: Adult, Male, 0301 basic medicine, Persons with Disabilities, Cost-Benefit Analysis, PYOGENIC SPONDYLODISCITIS, 03 medical and health sciences, 0302 clinical medicine, Cost of Illness, Recurrence, Cost-Benefit Analysis/methods, Delivery of Health Care/economics, LUMBAR SPINAL STENOSIS, Humans, Attention, OLDER-ADULTS, Aged, ddc:616, MUSCULOSKELETAL CONDITIONS, CLINICAL-FEATURES, PRIMARY-CARE, 1. No poverty, GLOBAL BURDEN, Middle Aged, Disabled Persons/psychology, 3. Good health, PHYSICAL-ACTIVITY, PROSPECTIVE COHORT, Social Class, SDG 1 - No Poverty, Low Back Pain/complications, AXIAL SPONDYLOARTHRITIS, Female, Delivery of Health Care, Low Back Pain, RD
Popis súboru: application/pdf
Prístupová URL adresa: https://cris.maastrichtuniversity.nl/ws/files/76001628/Smeets_2018_What_low_back_pain_is.pdf
https://pubmed.ncbi.nlm.nih.gov/29573870
http://wrap.warwick.ac.uk/100476/1/WRAP-What-low-back-pain-is-Underwood-2018.pdf
https://research.vu.nl/en/publications/79cd95b7-4b74-4c5a-bf1f-adf61bcc71f5
https://doi.org/10.1016/S0140-6736(18)30480-X
https://hdl.handle.net/1871.1/79cd95b7-4b74-4c5a-bf1f-adf61bcc71f5
https://research.monash.edu/en/publications/what-low-back-pain-is-and-why-we-need-to-pay-attention
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30480-X/fulltext
https://pubmed.ncbi.nlm.nih.gov/29573870/
https://researchers.mq.edu.au/en/publications/what-low-back-pain-is-and-why-we-need-to-pay-attention
https://www.narcis.nl/publication/RecordID/oai%3Acris.maastrichtuniversity.nl%3Apublications%2F950569e0-85cb-4562-9fb4-e53f25723cc0
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30480-X/fulltext
https://archive-ouverte.unige.ch/unige:110916
https://findresearcher.sdu.dk:8443/ws/files/143144961/What_low_back_pain_is_and_why_we_need_to_pay_attention.pdf -
14
Autori: a ďalší
Prispievatelia: a ďalší
Predmety: Aged, Cost-Benefit Analysis/methods, Female, Humans, Male, Metabolic Syndrome/economics, Middle Aged, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Popis súboru: application/pdf
Dostupnosť: https://dspace.library.uu.nl/handle/1874/443278
-
15
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: BMC Med
BMC Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Stol, D M, Over, E A B, Badenbroek, I F, Hollander, M, Nielen, M M J, Kraaijenhagen, R A, Schellevis, F G, de Wit, N J & de Wit, G A 2021, 'Cost-effectiveness of a stepwise cardiometabolic disease prevention program: results of a randomized controlled trial in primary care', BMC Medicine, vol. 19, no. 1, 57. https://doi.org/10.1186/s12916-021-01933-6Predmety: Male, Cost-Benefit Analysis, Modelling study, 03 medical and health sciences, 0302 clinical medicine, Cost-Benefit Analysis/methods, Diabetes type 2, Journal Article, Humans, 10. No inequality, Aged, Metabolic Syndrome, Research Support, Non-U.S. Gov't, Cost-effectiveness analysis, Prevention, Middle Aged, Primary care, Cardiovascular disease, Cardiometabolic diseases, Economic evaluation, 3. Good health, Metabolic Syndrome/economics, Randomized Controlled Trial, Medicine, Female, Research Article
Popis súboru: application/pdf
Prístupová URL adresa: https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-021-01933-6
https://pubmed.ncbi.nlm.nih.gov/33691699
https://doaj.org/article/ca31b6efba824714abff672e13e2bbc7
https://www.narcis.nl/publication/RecordID/oai%3Apure.atira.dk%3Apublications%2F70e7440e-41fe-455b-b71c-18207d101e8b
https://www.ncbi.nlm.nih.gov/pubmed/33691699
https://link.springer.com/article/10.1186/s12916-021-01933-6
https://link.springer.com/content/pdf/10.1186/s12916-021-01933-6.pdf
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-021-01933-6
https://europepmc.org/article/PMC/PMC7948329
https://research.vumc.nl/en/publications/70e7440e-41fe-455b-b71c-18207d101e8b
https://dspace.library.uu.nl/handle/1874/443278
https://rivm.openrepository.com/handle/10029/653125
https://hdl.handle.net/10029/624781 -
16
Autori: Gonzalez-Perez, J. G.
Zdroj: The European Journal of Health Economics, 2002 Jan 01. 3(2), 131-136.
Prístupová URL adresa: https://www.jstor.org/stable/3569959
-
17
Autori: a ďalší
Zdroj: Albuquerque De Almeida, F, Al, M J, Koymans, R, Riistama, J, Pauws, S & Severens, J L 2020, 'Impact of hospitalisation on health-related quality of life in patients with chronic heart failure', Health and Quality of Life Outcomes, vol. 18, no. 1, 262, pp. 1-10. https://doi.org/10.1186/s12955-020-01508-8
Predmety: Aged, 80 and over, Cohort Studies, Cost-Benefit Analysis/methods, Female, Heart Failure/economics, Hospitalization, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires
-
18
Autori: a ďalší
Zdroj: PLoS Med
PLoS Medicine, Vol 18, Iss 10, p e1003815 (2021)Predmety: 0301 basic medicine, COVID-19 Vaccines, Cost-Benefit Analysis, Population, Vaccine efficacy, Social Sciences, Coronavirus Disease 2019 Research, FOS: Health sciences, Cost effectiveness, Disability-adjusted life year, 03 medical and health sciences, COVID-19, Health Impact Assessment/trends, Health Impact Assessment/economics [MeSH], COVID-19 Vaccines/economics [MeSH], Vaccination/trends, Quality-Adjusted Life Years, General Medicine, Quality-Adjusted Life Years [MeSH], COVID-19 Vaccines/economics, COVID-19/epidemiology [MeSH], Cost-Benefit Analysis/trends, COVID-19 Vaccines/administration, Humans, Vaccination/economics [MeSH], Health Impact Assessment/economics, Pakistan/epidemiology, Vaccination/trends [MeSH], Health Impact Assessment/methods [MeSH], Humans [MeSH], Cost-Benefit Analysis/methods, Cost-Benefit Analysis/methods [MeSH], COVID-19/economics [MeSH], COVID-19/economics, Models, Economic [MeSH], Health Impact Assessment/trends [MeSH], Models, Economic, Health Impact Assessment/methods, COVID-19/prevention, Vaccination/economics, Cost-Benefit Analysis/trends [MeSH], Pakistan/epidemiology [MeSH], COVID-19/epidemiology, Engineering, 0302 clinical medicine, Sociology, Virology, Health Sciences, FOS: Mathematics, Pathology, Risk analysis (engineering), Pakistan, Civil engineering, Demography, Modeling the Dynamics of COVID-19 Pandemic, Vaccination, Economic impact analysis, 1. No poverty, Disease burden, Economic evaluation, FOS: Sociology, 3. Good health, Infectious Diseases, Environmental health, Health, Modeling and Simulation, Physical Sciences, 8. Economic growth, Factors Affecting Vaccine Hesitancy and Acceptance, Medicine, Vaccination Intention, Health Impact Assessment, Mathematics, FOS: Civil engineering, Research Article
Prístupová URL adresa: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003815&type=printable
https://ecommons.aku.edu/cgi/viewcontent.cgi?article=1953&context=pakistan_fhs_mc_chs_chs
https://pubmed.ncbi.nlm.nih.gov/34606520
https://doaj.org/article/5483efc8283b4575ac5bc7800eb4b403
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523052
https://www.ncbi.nlm.nih.gov/pubmed/34606520
https://researchonline.lshtm.ac.uk/id/eprint/4659836/
https://dx.plos.org/10.1371/journal.pmed.1003815
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003815
https://pubmed.ncbi.nlm.nih.gov/34606520/
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/ar/ppmedrxiv-21252338
http://medrxiv.org/cgi/content/short/2021.02.24.21252338
https://researchonline.lshtm.ac.uk/4659836
https://www.medrxiv.org/content/10.1101/2021.02.24.21252338v2
https://repository.publisso.de/resource/frl:6439205 -
19
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: ISSN: 1473-3099.
Predmety: MESH: Animals, MESH: Bites and Stings / virology, MESH: Rabies / prevention & control, MESH: Rabies / virology, MESH: Child, Preschool, MESH: Rabies Vaccines / economics, MESH: Rabies Vaccines / therapeutic use, MESH: Rabies virus / immunology, MESH: Rabies virus / isolation & purification, MESH: Vaccination / economics, MESH: World Health Organization, MESH: Cost-Benefit Analysis / methods, MESH: Incidence, MESH: Dog Diseases / prevention & control, MESH: Dogs, MESH: Endemic Diseases / prevention & control, MESH: Female, MESH: Humans, MESH: Immunoglobulins / therapeutic use, MESH: Male, MESH: Models, Economic, MESH: Post-Exposure Prophylaxis / economics, MESH: Post-Exposure Prophylaxis / methods, MESH: Quality-Adjusted Life Years, MESH: Rabies / epidemiology, MESH: Rabies / mortality, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Relation: info:eu-repo/semantics/altIdentifier/pmid/30472178; PUBMED: 30472178; PUBMEDCENTRAL: PMC6300480
-
20
Autori: a ďalší
Zdroj: Gyrd-Hansen, D, Rose Olsen, K, Bollweg, K, Kronborg, C, Ebinger, M & Audebert, HJ 2015, ' Cost-effectiveness estimate of prehospital thrombolysis : results of the PHANTOM-S Study ', Neurology, vol. 84, no. 11, pp. 1090-1097 . https://doi.org/10.1212/WNL.0000000000001366
Predmety: Adult, Aged, 80 and over, Male, Emergency Medical Services, Adolescent, Cost-Benefit Analysis, Thrombolytic Therapy/economics, Middle Aged, Time-to-Treatment, 3. Good health, Stroke, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Cost-Benefit Analysis/methods, 80 and over, Emergency Medical Services/economics, Humans, Female, Thrombolytic Therapy, Prospective Studies, Stroke/drug therapy, Aged
Full Text Finder
Nájsť tento článok vo Web of Science